CN1175258A - 用作抗病毒药的噻吩并 嗪酮类衍生物 - Google Patents

用作抗病毒药的噻吩并 嗪酮类衍生物 Download PDF

Info

Publication number
CN1175258A
CN1175258A CN95197615A CN95197615A CN1175258A CN 1175258 A CN1175258 A CN 1175258A CN 95197615 A CN95197615 A CN 95197615A CN 95197615 A CN95197615 A CN 95197615A CN 1175258 A CN1175258 A CN 1175258A
Authority
CN
China
Prior art keywords
compound
benzyloxycarbonyl
amino
exchangeable
thieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95197615A
Other languages
English (en)
Chinese (zh)
Inventor
R·L·扎维斯特
M·J·帕列特
H·T·塞拉菲诺瓦斯卡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of CN1175258A publication Critical patent/CN1175258A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN95197615A 1994-12-22 1995-12-20 用作抗病毒药的噻吩并 嗪酮类衍生物 Pending CN1175258A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9426021.3 1994-12-22
GBGB9426021.3A GB9426021D0 (en) 1994-12-22 1994-12-22 Pharmaceuticals

Publications (1)

Publication Number Publication Date
CN1175258A true CN1175258A (zh) 1998-03-04

Family

ID=10766452

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95197615A Pending CN1175258A (zh) 1994-12-22 1995-12-20 用作抗病毒药的噻吩并 嗪酮类衍生物

Country Status (14)

Country Link
EP (1) EP0799230A1 (cs)
JP (1) JPH11500710A (cs)
CN (1) CN1175258A (cs)
AU (1) AU4347596A (cs)
BR (1) BR9510418A (cs)
CA (1) CA2208458A1 (cs)
CZ (1) CZ195897A3 (cs)
FI (1) FI972585A7 (cs)
GB (1) GB9426021D0 (cs)
HU (1) HUT77123A (cs)
NO (1) NO972905L (cs)
PL (1) PL320889A1 (cs)
WO (1) WO1996019482A1 (cs)
ZA (1) ZA9510823B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601544D0 (en) 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
WO1997027200A1 (en) * 1996-01-26 1997-07-31 Smithkline Beecham Plc Thienoxazinone derivatives useful as antiviral agents
AU3339797A (en) * 1996-06-20 1998-01-07 Smithkline Beecham Plc 4h-3,1-benzoxazin-4-one derivatives and analogs as antiviral agents
WO1998045298A1 (en) * 1997-04-10 1998-10-15 Smithkline Beecham Plc Antiviral agents
GB9710928D0 (en) * 1997-05-29 1997-07-23 Smithkline Beecham Plc Pharmaceuticals
WO2003053944A1 (en) 2001-12-20 2003-07-03 Osi Pharmaceuticals, Inc. Pancreatic lipase inhibitor compounds, their synthesis and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681351A (en) * 1970-04-15 1972-08-01 Ian Wellings CERTAIN 5,6,7,8-TETRAHYDRO-5,8-ETHANO-PYRIDINO{8 2,3-b{9 -THIENO{8 5,4-d{9 PYRIMIDINES
CA1094063A (en) * 1977-08-22 1981-01-20 Davis L. Temple, Jr. Thieno ¬2,3-d| pyrimidine antiallergic agents

Also Published As

Publication number Publication date
AU4347596A (en) 1996-07-10
MX9704737A (es) 1997-10-31
PL320889A1 (en) 1997-11-10
EP0799230A1 (en) 1997-10-08
NO972905L (no) 1997-08-18
HUT77123A (hu) 1998-03-02
CA2208458A1 (en) 1996-06-27
FI972585L (fi) 1997-08-19
GB9426021D0 (en) 1995-02-22
JPH11500710A (ja) 1999-01-19
NO972905D0 (no) 1997-06-20
WO1996019482A1 (en) 1996-06-27
ZA9510823B (en) 1996-08-16
FI972585A0 (fi) 1997-06-17
FI972585A7 (fi) 1997-08-19
BR9510418A (pt) 1998-05-19
CZ195897A3 (cs) 1998-03-18

Similar Documents

Publication Publication Date Title
KR0177838B1 (ko) 인체 면역 결핍 비루스(hiv) 프로테아제의 활성을 억제할 수 있는 펩티드, 그의 제조 방법, 및 그의 치료적 용도
EP0975353B1 (en) Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
PL185693B1 (pl) Związki peptydowe i kompozycje farmaceutyczne
EP0646596B1 (de) Nukleinsäure-bindende Oligomere mit C-Verzweigung für Therapie und Diagnostik
IE913572A1 (en) Novel compounds
CN1175258A (zh) 用作抗病毒药的噻吩并 嗪酮类衍生物
CA2080227A1 (en) Phosphonopeptides with collagenase inhibiting activity
WO1997027200A1 (en) Thienoxazinone derivatives useful as antiviral agents
HK1039276A1 (en) Hydroxamate-containing cysteine and serine protease inhibitors
JP5501961B2 (ja) システインプロテアーゼ阻害剤
US11479570B2 (en) Pentafluorophosphate derivative, its uses and an appropriate manufacturing method
ES2291324T3 (es) Metodos para la sintesis de derivados de hipoxantina con sustitucion en la posicion 9.
IE911165A1 (en) Novel compounds
AU2005201198B2 (en) New 4-oxo-4,6,7,8-tetrahydropyrrolo [1,2-a]pyrazine-6-carboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
KR19990071822A (ko) α-케토에스테르 및 α-케토아미드의 아실화된 에놀 유도체
Poojary et al. Synthesis and biological evaluation of pseudostellarin B
MXPA97004737A (en) Derivatives of tienoxazinone useful as antivira agents
KR100382778B1 (ko) 항증식제및garft억제제로유용한화합물
HK1025511B (en) Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
HK1140480B (en) Cysteine protease inhibitors
JP2003219874A (ja) Ｒｎａに選択的に結合するペプチド核酸をアンチセンスオリゴヌクレオチドとして用いる方法、及び該ペプチド核酸の製造方法
KR20000013029A (ko) N-(4-피페리딘)벤즈아미드의 제조방법, 그 중간체 및그 중간체의 제조방법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication